Literature DB >> 26884195

Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading.

Marija Iljina1, Gonzalo A Garcia1, Mathew H Horrocks1, Laura Tosatto2, Minee L Choi3, Kristina A Ganzinger1, Andrey Y Abramov3, Sonia Gandhi4, Nicholas W Wood3, Nunilo Cremades1, Christopher M Dobson1, Tuomas P J Knowles5, David Klenerman5.   

Abstract

The protein alpha-synuclein (αS) self-assembles into small oligomeric species and subsequently into amyloid fibrils that accumulate and proliferate during the development of Parkinson's disease. However, the quantitative characterization of the aggregation and spreading of αS remains challenging to achieve. Previously, we identified a conformational conversion step leading from the initially formed oligomers to more compact oligomers preceding fibril formation. Here, by a combination of single-molecule fluorescence measurements and kinetic analysis, we find that the reaction in solution involves two unimolecular structural conversion steps, from the disordered to more compact oligomers and then to fibrils, which can elongate by further monomer addition. We have obtained individual rate constants for these key microscopic steps by applying a global kinetic analysis to both the decrease in the concentration of monomeric protein molecules and the increase in oligomer concentrations over a 0.5-140-µM range of αS. The resulting explicit kinetic model of αS aggregation has been used to quantitatively explore seeding the reaction by either the compact oligomers or fibrils. Our predictions reveal that, although fibrils are more effective at seeding than oligomers, very high numbers of seeds of either type, of the order of 10(4), are required to achieve efficient seeding and bypass the slow generation of aggregates through primary nucleation. Complementary cellular experiments demonstrated that two orders of magnitude lower numbers of oligomers were sufficient to generate high levels of reactive oxygen species, suggesting that effective templated seeding is likely to require both the presence of template aggregates and conditions of cellular stress.

Entities:  

Keywords:  amyloid aggregation; kinetic analysis; neurodegeneration; prion-like propagation; templated seeding

Mesh:

Substances:

Year:  2016        PMID: 26884195      PMCID: PMC4780632          DOI: 10.1073/pnas.1524128113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

Review 1.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Cell biology. A unifying role for prions in neurodegenerative diseases.

Authors:  Stanley B Prusiner
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

3.  Determination of the fraction and stoichiometry of femtomolar levels of biomolecular complexes in an excess of monomer using single-molecule, two-color coincidence detection.

Authors:  Angel Orte; Richard Clarke; Shankar Balasubramanian; David Klenerman
Journal:  Anal Chem       Date:  2006-11-15       Impact factor: 6.986

Review 4.  Structural neurology: are seeds at the root of neuronal degeneration?

Authors:  P T Lansbury
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

5.  Nucleation-conversion-polymerization reactions of biological macromolecules with prenucleation clusters.

Authors:  Gonzalo A Garcia; Samuel I A Cohen; Christopher M Dobson; Tuomas P J Knowles
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2014-03-24

6.  Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

Authors:  M Hashimoto; L J Hsu; Y Xia; A Takeda; A Sisk; M Sundsmo; E Masliah
Journal:  Neuroreport       Date:  1999-03-17       Impact factor: 1.837

7.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Authors:  Jia-Yi Li; Elisabet Englund; Janice L Holton; Denis Soulet; Peter Hagell; Andrew J Lees; Tammaryn Lashley; Niall P Quinn; Stig Rehncrona; Anders Björklund; Håkan Widner; Tamas Revesz; Olle Lindvall; Patrik Brundin
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

Review 8.  The synucleins.

Authors:  Julia M George
Journal:  Genome Biol       Date:  2001-12-20       Impact factor: 13.583

9.  Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation.

Authors:  Alexander K Buell; Céline Galvagnion; Ricardo Gaspar; Emma Sparr; Michele Vendruscolo; Tuomas P J Knowles; Sara Linse; Christopher M Dobson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-09       Impact factor: 11.205

10.  Prion-like spreading of pathological α-synuclein in brain.

Authors:  Masami Masuda-Suzukake; Takashi Nonaka; Masato Hosokawa; Takayuki Oikawa; Tetsuaki Arai; Haruhiko Akiyama; David M A Mann; Masato Hasegawa
Journal:  Brain       Date:  2013-03-06       Impact factor: 13.501

View more
  82 in total

1.  Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.

Authors:  Zachary A Sorrentino; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Kevin H Strang; Jason Caldwell; Benoit I Giasson
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

Review 2.  The emerging role of α-synuclein truncation in aggregation and disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

Review 3.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

Review 4.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

5.  Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.

Authors:  P A Broderick; L Wenning; Y-S Li
Journal:  J Neural Transm (Vienna)       Date:  2016-10-28       Impact factor: 3.575

6.  Excitation Energy Migration Unveils Fuzzy Interfaces within the Amyloid Architecture.

Authors:  Anupa Majumdar; Debapriya Das; Priyanka Madhu; Anamika Avni; Samrat Mukhopadhyay
Journal:  Biophys J       Date:  2020-04-23       Impact factor: 4.033

7.  Kinetic diversity of amyloid oligomers.

Authors:  Alexander J Dear; Thomas C T Michaels; Georg Meisl; David Klenerman; Si Wu; Sarah Perrett; Sara Linse; Christopher M Dobson; Tuomas P J Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-15       Impact factor: 11.205

8.  Pre-aggregation kinetics and intermediates of α-synuclein monitored by the ESIPT probe 7MFE.

Authors:  Jonathan A Fauerbach; Thomas M Jovin
Journal:  Eur Biophys J       Date:  2017-12-18       Impact factor: 1.733

9.  Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.

Authors:  Chunhua Dong; Craig R Garen; Pascal Mercier; Nils O Petersen; Michael T Woodside
Journal:  Protein Sci       Date:  2019-08-02       Impact factor: 6.725

10.  Organizing biochemistry in space and time using prion-like self-assembly.

Authors:  Christopher M Jakobson; Daniel F Jarosz
Journal:  Curr Opin Syst Biol       Date:  2017-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.